Your Survivorship Care Plan: — What Should Be In It

The decision to stop a treatment that is working — particularly immunotherapy in deep remission — is a clinical judgement based on how long you have been in remission, the behaviour of your cancer type, and the evolving evidence for your situation. ASCO and ESMO guidance supports planned discontinuation in certain settings where remission has been sustained. This should be a shared decision with your oncologist, not something that happens without a full explanation. Ask what the recommendation is based on, and what would need to change for restarting to be considered.

For many patients who stopped in remission, restarting the same or a similar treatment is clinically possible, and a proportion do respond again. Whether it is appropriate depends on why it was stopped, how long ago, and how the disease has changed. This is worth asking your oncologist before stopping — not because recurrence is certain, but because knowing the plan in advance makes the possibility easier to live with. A survivorship plan that addresses this specifically gives you something to refer back to if things change.

In India, follow-up responsibility after cancer treatment is not always clearly assigned, and this is one of the most important things your survivorship plan should specify. Your oncologist may hand some follow-up to a general practitioner or to a specialist at a centre closer to you. The plan should name that person, confirm they have your treatment record, and say what they are responsible for monitoring. If this is not clear before your last active treatment visit, ask directly: who is my point of contact afterwards, and how do I reach them?

For most people who have had cancer, some background awareness about symptoms and changes does not go away entirely — and that is realistic, not catastrophic thinking. What tends to change over time, for people who remain well, is the intensity of that awareness. A clear surveillance schedule, where you know what is being monitored and when the next check is, helps many people manage the waiting rather than feeling suspended in uncertainty. If anxiety about recurrence is interfering with daily life, mention it at your next appointment — there is support available.

General guidance from ASCO and the World Cancer Research Fund supports maintaining a healthy weight, staying physically active, and eating a varied diet rich in plant-based foods — for general health, not as a guaranteed way to prevent recurrence. Do not stop eating something or start a supplement without telling your oncology team first. Some supplements interact with treatments you may still be monitored for, and many claims made online about cancer recovery are not supported by evidence. Consistent daily habits matter more than any single food or product.

Yes. The period after treatment ends — particularly when there is no longer an active treatment to take — is consistently described as one of the harder transitions for patients and families. CION centres have oncology counselling and support services available. Psycho-oncology, which addresses the emotional experience of cancer and its treatment, is a recognised clinical field. If anxiety is making it hard to sleep, work or be with your family, mention it at your next appointment. It is a clinical issue worth raising, not a sign that something is wrong with you.